Mikako Nishida

851 total citations · 1 hit paper
12 papers, 689 citations indexed

About

Mikako Nishida is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Mikako Nishida has authored 12 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Immunology. Recurrent topics in Mikako Nishida's work include Metabolism, Diabetes, and Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Mikako Nishida is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Mikako Nishida collaborates with scholars based in Japan, United States and Czechia. Mikako Nishida's co-authors include Heiichiro Udono, Shingo Eikawa, Eiichi Nakayama, Shusaku Mizukami, Chihiro Yamazaki, Yuki Kunisada, Toshiyuki Kunisada, Takenori Uehara, Tomohiro Fujiwara and Toshifumi Ozaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Frontiers in Immunology and eLife.

In The Last Decade

Mikako Nishida

11 papers receiving 684 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune-mediated antitumor effect by type 2 diabetes drug, metformin

2015 433 citations Shingo Eikawa, Mikako Nishida et al. Proceedings of the National Academy of Sciences profile →

Peers

Mikako Nishida

MB

ONCOL

IMMUN

CR

SURGE

Irene Gómez Spain

Shucai Yang China

Songtao Lai China

Dianyun Ren China

Ayush Arya United States

Kousik Kesh United States

Ole Helm Germany

Yanhui Yin China

Xinyun Xu China

Yu‐zhong Duan China

Irene Gómez Spain

Mikako Nishida

338 ×0.9

MB

358 ×1.2

ONCOL

145 ×0.6

IMMUN

156 ×0.9

CR

55 ×0.7

SURGE

Citations per year, relative to Mikako Nishida Mikako Nishida (= 1×) peers Irene Gómez

Countries citing papers authored by Mikako Nishida

Since Specialization

Citations

This map shows the geographic impact of Mikako Nishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikako Nishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikako Nishida more than expected).

Fields of papers citing papers by Mikako Nishida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikako Nishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikako Nishida. The network helps show where Mikako Nishida may publish in the future.

Co-authorship network of co-authors of Mikako Nishida

This figure shows the co-authorship network connecting the top 25 collaborators of Mikako Nishida. A scholar is included among the top collaborators of Mikako Nishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikako Nishida. Mikako Nishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Saito, Yukihiro, Kazufumi Nakamura, Yuki Katanosaka, et al.. (2025). Specific induction of right ventricular-like cardiomyocytes from human pluripotent stem cells. Stem Cell Research & Therapy. 16(1). 519–519.

2.

Nishida, Mikako, et al.. (2024). Metformin synergizes with PD-1 blockade to promote normalization of tumor vessels via CD8T cells and IFNγ. Proceedings of the National Academy of Sciences. 121(30). e2404778121–e2404778121. 7 indexed citations

3.

Harada, Yoichiro, Takehiro Suzuki, Akiyoshi Hirayama, et al.. (2023). Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells. eLife. 12. 9 indexed citations

4.

Akagi, Satoshi, Kazufumi Nakamura, Megumi Kondo, et al.. (2023). Evidence for Hypoxia-Induced Shift in ATP Production from Glycolysis to Mitochondrial Respiration in Pulmonary Artery Smooth Muscle Cells in Pulmonary Arterial Hypertension. Journal of Clinical Medicine. 12(15). 5028–5028. 7 indexed citations

5.

Nishida, Mikako, et al.. (2022). Nutrient Condition in the Microenvironment Determines Essential Metabolisms of CD8+ T Cells for Enhanced IFNγ Production by Metformin. Frontiers in Immunology. 13. 864225–864225. 17 indexed citations

6.

Nishida, Mikako, et al.. (2022). Blocking EP4 down-regulates tumor metabolism and synergizes with anti-PD-1 therapy to activate natural killer cells in a lung adenocarcinoma model. International Immunology. 34(6). 293–302. 7 indexed citations

7.

Udono, Heiichiro & Mikako Nishida. (2022). Metformin-ROS-Nrf2 connection in the host defense mechanism against oxidative stress, apoptosis, cancers, and ageing. Biochimica et Biophysica Acta (BBA) - General Subjects. 1866(8). 130171–130171. 18 indexed citations

8.

Nishida, Mikako, Taisaku Ogawa, Keita Koseki, et al.. (2021). Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes. Journal for ImmunoTherapy of Cancer. 9(9). e002954–e002954. 79 indexed citations

9.

Udono, Heiichiro & Mikako Nishida. (2021). Pharmacological effects on anaplerotic pathways alter the metabolic landscape in the tumor microenvironment, causing unpredictable, sustained anti-tumor immunity. International Immunology. 34(3). 133–140. 1 indexed citations

10.

Hirayama, Takanori, Yasuhiro Nagata, Mikako Nishida, et al.. (2019). Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment. Anticancer Research. 39(9). 4699–4709. 9 indexed citations

11.

Uehara, Takenori, Shingo Eikawa, Mikako Nishida, et al.. (2018). Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects. International Immunology. 31(4). 187–198. 102 indexed citations

12.

Eikawa, Shingo, Mikako Nishida, Shusaku Mizukami, et al.. (2015). Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proceedings of the National Academy of Sciences. 112(6). 1809–1814. 433 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact